CA2074841A1 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
CA2074841A1
CA2074841A1 CA002074841A CA2074841A CA2074841A1 CA 2074841 A1 CA2074841 A1 CA 2074841A1 CA 002074841 A CA002074841 A CA 002074841A CA 2074841 A CA2074841 A CA 2074841A CA 2074841 A1 CA2074841 A1 CA 2074841A1
Authority
CA
Canada
Prior art keywords
group
halo
alkyl
hydrogen
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002074841A
Other languages
English (en)
French (fr)
Inventor
Roger B. Titman
Michael H. Hockley
Onkar S. Gill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909002315A external-priority patent/GB9002315D0/en
Priority claimed from GB909002314A external-priority patent/GB9002314D0/en
Priority claimed from GB909002425A external-priority patent/GB9002425D0/en
Application filed by Individual filed Critical Individual
Publication of CA2074841A1 publication Critical patent/CA2074841A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
CA002074841A 1990-02-02 1991-01-26 Therapeutic agents Abandoned CA2074841A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB909002315A GB9002315D0 (en) 1990-02-02 1990-02-02 Therapeutic agents
GB9002315.1 1990-02-02
GB909002314A GB9002314D0 (en) 1990-02-02 1990-02-02 Therapeutic agents
GB9002314.4 1990-02-02
GB9002425.8 1990-02-06
GB909002425A GB9002425D0 (en) 1990-02-06 1990-02-06 Therapeutic agents

Publications (1)

Publication Number Publication Date
CA2074841A1 true CA2074841A1 (en) 1991-08-03

Family

ID=27264917

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002074841A Abandoned CA2074841A1 (en) 1990-02-02 1991-01-26 Therapeutic agents

Country Status (14)

Country Link
EP (1) EP0539372A1 (cs)
JP (1) JPH05505180A (cs)
KR (1) KR927003599A (cs)
AU (1) AU7220991A (cs)
BG (1) BG96715A (cs)
BR (1) BR9105984A (cs)
CA (1) CA2074841A1 (cs)
CS (1) CS23891A2 (cs)
FI (1) FI923486A0 (cs)
HU (1) HU9202510D0 (cs)
IE (1) IE910365A1 (cs)
IL (1) IL97114A0 (cs)
PT (1) PT96656A (cs)
WO (1) WO1991011448A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116241D0 (en) * 1991-07-27 1991-09-11 Boots Co Plc Therapeutic agents
CA2263586A1 (en) * 1996-09-05 1998-03-12 Eifion Phillips Novel aryl-pyridazines
SE0102404D0 (sv) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
WO2004048378A1 (en) 2002-11-22 2004-06-10 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity
EP1572689B1 (en) * 2002-12-16 2009-03-11 Active Biotech AB Tetracyclic immunomodulatory compounds
CN103626787B (zh) * 2013-12-10 2016-06-15 沈阳药科大学 噻吩并硫杂类化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents

Also Published As

Publication number Publication date
KR927003599A (ko) 1992-12-18
PT96656A (pt) 1991-10-31
HU9202510D0 (en) 1992-10-28
CS23891A2 (en) 1991-09-15
AU7220991A (en) 1991-08-21
FI923486A7 (fi) 1992-07-31
WO1991011448A1 (en) 1991-08-08
IE910365A1 (en) 1991-08-14
IL97114A0 (en) 1992-03-29
FI923486A0 (fi) 1992-07-31
EP0539372A1 (en) 1993-05-05
BG96715A (bg) 1993-12-24
JPH05505180A (ja) 1993-08-05
BR9105984A (pt) 1992-11-10

Similar Documents

Publication Publication Date Title
EP0626956B1 (en) Quinolylbenzofuran derivatives as leukotriene antagonists
CA2927567C (en) Bromodomain inhibitors
EP0823413B1 (en) Intermediates for the preparation of benzoheterocyclic compounds
WO2007032466A1 (ja) 複素環化合物、その製造方法並びに用途
JPH02141A (ja) 新規化合物、その製法及びそれを含む医薬組成物
WO2009060209A1 (en) 6,6-fused bicyclic aromatic compounds and their therapeuti use
NZ231699A (en) Substituted benzopyran, quinoline and naphthalene derivatives, preparation and pharmaceutical compositions thereof
JPH11508267A (ja) ピラゾール化合物および医薬組成物
JPH0517470A (ja) ピラゾール誘導体
JP3120857B2 (ja) 新規な縮合複素環化合物とこれを用いた抗喘息剤
CA2074841A1 (en) Therapeutic agents
JPWO1991012251A1 (ja) 新規な縮合複素環化合物とこれを用いた抗喘息剤
TWI429641B (zh) 哌啶衍生物
CA1244436A (en) 4-quinolone derivatives
JPH05125079A (ja) ピラゾロ［１，５−ａピリミジン誘導体
AU2008215921A1 (en) Delta 9 tetrahydrocannabinol derivatives
EP0421749B1 (en) 3-Aroyl-2-oxindole-1-carboxamides
US4128549A (en) Precursors of 4-(1-alkyl-4-piperidylidene-4H-benzo[4,5]cyclohepta-[1,2-b]thiophen-10(9H)-ones
JP3162175B2 (ja) クロマン誘導体若しくはジヒドロベンゾフラン誘導体
WO1989005808A1 (en) Esters of nitric acid and a pharmaceutical composition
WO1991009031A1 (en) Trifluoromethyl substituted compounds and a pharmaceutical composition
JP3479708B2 (ja) 安息香酸誘導体
EP0398665A1 (en) Benzopyran derivatives
JP3512236B2 (ja) ピラゾロピリジンオキソアルキレン酸誘導体及びその製造法
EP0366273A1 (en) Benzopyran derivatives with smooth muscle relaxant activity

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19940726